Plus Therapeutics (PSTV) Non Operating Income (2011 - 2026)
Plus Therapeutics (PSTV) reported Non Operating Income of $173000.0 for Q1 2026, up 101.25% year-over-year from $85963.7 in Q1 2025, and up 496.55% quarter-over-quarter from $29000.0 in Q4 2025.
Plus Therapeutics (PSTV) Non Operating Income (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 16 years of Non Operating Income data on file, last reported at $173000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at $173000.0, up 101.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 million (up 157.03% YoY), and the FY2025 annual result was -$7.1 million, down 512.81% from the prior year.
- Non Operating Income rose to $173000.0 in Q1 2026 per PSTV's latest filing, from $29000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $6.7 million in Q2 2025 and troughed at -$13.9 million in Q1 2025.
- A 5-year average of -$338588.2 and a median of $29000.0 in 2025 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income jumped 9362.5% in 2024, then plunged 36586.84% in 2025.
- A 5-year view of Non Operating Income shows it stood at -$86000.0 in 2022, then soared by 155.81% to $48000.0 in 2023, then sank by 106.25% to -$3000.0 in 2024, then surged by 1066.67% to $29000.0 in 2025, then surged by 496.55% to $173000.0 in 2026.
- Business Quant data shows PSTV's Non Operating Income at $173000.0 in Q1 2026, $29000.0 in Q4 2025, and $59000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 9.35 Mn |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | 173,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 6.69 Mn |
| Mar 31, 2025 | -13.87 Mn |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | 925,000.00 |
| Jun 30, 2024 | 757,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | -83,000.00 |
| Dec 31, 2022 | -86,000.00 |
| Sep 30, 2022 | -125,000.00 |
| Jun 30, 2022 | -162,000.00 |
| Mar 31, 2022 | -190,000.00 |
| Dec 31, 2021 | -216,000.00 |
| Sep 30, 2021 | -225,000.00 |
| Jun 30, 2021 | -225,000.00 |